Matches in SemOpenAlex for { <https://semopenalex.org/work/W2050023063> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W2050023063 endingPage "771" @default.
- W2050023063 startingPage "766" @default.
- W2050023063 abstract "Adjunctive fluvoxamine inhibits clozapine metabolism and decreases plasma norclozapine (a toxic metabolite of clozapine) to clozapine ratios. This study aimed to demonstrate the effects of fluvoxamine on clozapine-related weight gain, hyperglycemia, and lipid abnormalities.Sixty-eight treatment-resistant inpatients with a DSM-IV diagnosis of schizophrenia were randomly assigned to 2 treatment groups for 12 weeks. The monotherapy group (N = 34) received clozapine (< or = 600 mg/day). The coadministration group (N = 34) received fluvoxamine (50 mg/day) plus low-dose clozapine (< or = 250 mg/day). The study was conducted from August 1999 to October 2002.The 2 groups were similar in demographic data; baseline body weight and body mass index (BMI); baseline serum glucose, triglyceride, and cholesterol levels; and steady-state plasma clozapine concentration. The monotherapy patients (but not the coadministration patients) had significantly higher (p < .05) body weight, BMI, and serum glucose and triglyceride levels after treatment than at baseline. At week 12, the monotherapy patients also had significantly higher glucose (p = .035), triglyceride (p = .041), and norclozapine (p = .009) (and numerically higher cholesterol) levels than the cotreatment patients. The changes in weight and serum glucose and triglyceride levels were significantly correlated (p = .026, p = .005, and p = .028, respectively) with the plasma concentration of norclozapine but not with plasma levels of clozapine.These results suggest that fluvoxamine cotreatment can attenuate weight gain and metabolic disturbances in clozapine-treated patients. Plasma levels of norclozapine, but not clozapine, are associated with increases in weight and serum glucose and triglyceride levels. Of note, coadministration of fluvoxamine could increase plasma clozapine levels markedly and carry the risk of adverse events. If this combined treatment is applied, conservative introduction with reduced clozapine dosage and careful therapeutic drug monitoring of clozapine concentration is recommended." @default.
- W2050023063 created "2016-06-24" @default.
- W2050023063 creator A5000923658 @default.
- W2050023063 creator A5012266795 @default.
- W2050023063 creator A5036998349 @default.
- W2050023063 creator A5046538397 @default.
- W2050023063 creator A5053063869 @default.
- W2050023063 date "2004-06-15" @default.
- W2050023063 modified "2023-09-25" @default.
- W2050023063 title "Adjunctive Fluvoxamine Inhibits Clozapine-Related Weight Gain and Metabolic Disturbances" @default.
- W2050023063 doi "https://doi.org/10.4088/jcp.v65n0607" @default.
- W2050023063 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15291653" @default.
- W2050023063 hasPublicationYear "2004" @default.
- W2050023063 type Work @default.
- W2050023063 sameAs 2050023063 @default.
- W2050023063 citedByCount "114" @default.
- W2050023063 countsByYear W20500230632012 @default.
- W2050023063 countsByYear W20500230632013 @default.
- W2050023063 countsByYear W20500230632014 @default.
- W2050023063 countsByYear W20500230632015 @default.
- W2050023063 countsByYear W20500230632016 @default.
- W2050023063 countsByYear W20500230632017 @default.
- W2050023063 countsByYear W20500230632018 @default.
- W2050023063 countsByYear W20500230632019 @default.
- W2050023063 countsByYear W20500230632020 @default.
- W2050023063 countsByYear W20500230632021 @default.
- W2050023063 countsByYear W20500230632022 @default.
- W2050023063 countsByYear W20500230632023 @default.
- W2050023063 crossrefType "journal-article" @default.
- W2050023063 hasAuthorship W2050023063A5000923658 @default.
- W2050023063 hasAuthorship W2050023063A5012266795 @default.
- W2050023063 hasAuthorship W2050023063A5036998349 @default.
- W2050023063 hasAuthorship W2050023063A5046538397 @default.
- W2050023063 hasAuthorship W2050023063A5053063869 @default.
- W2050023063 hasConcept C112705442 @default.
- W2050023063 hasConcept C118552586 @default.
- W2050023063 hasConcept C126322002 @default.
- W2050023063 hasConcept C134018914 @default.
- W2050023063 hasConcept C147583825 @default.
- W2050023063 hasConcept C170493617 @default.
- W2050023063 hasConcept C2775864247 @default.
- W2050023063 hasConcept C2776134451 @default.
- W2050023063 hasConcept C2776412080 @default.
- W2050023063 hasConcept C2776921671 @default.
- W2050023063 hasConcept C2778163477 @default.
- W2050023063 hasConcept C2778913445 @default.
- W2050023063 hasConcept C2779910183 @default.
- W2050023063 hasConcept C2780221984 @default.
- W2050023063 hasConcept C2780320433 @default.
- W2050023063 hasConcept C2780494398 @default.
- W2050023063 hasConcept C2780864610 @default.
- W2050023063 hasConcept C3018162438 @default.
- W2050023063 hasConcept C71924100 @default.
- W2050023063 hasConcept C98274493 @default.
- W2050023063 hasConceptScore W2050023063C112705442 @default.
- W2050023063 hasConceptScore W2050023063C118552586 @default.
- W2050023063 hasConceptScore W2050023063C126322002 @default.
- W2050023063 hasConceptScore W2050023063C134018914 @default.
- W2050023063 hasConceptScore W2050023063C147583825 @default.
- W2050023063 hasConceptScore W2050023063C170493617 @default.
- W2050023063 hasConceptScore W2050023063C2775864247 @default.
- W2050023063 hasConceptScore W2050023063C2776134451 @default.
- W2050023063 hasConceptScore W2050023063C2776412080 @default.
- W2050023063 hasConceptScore W2050023063C2776921671 @default.
- W2050023063 hasConceptScore W2050023063C2778163477 @default.
- W2050023063 hasConceptScore W2050023063C2778913445 @default.
- W2050023063 hasConceptScore W2050023063C2779910183 @default.
- W2050023063 hasConceptScore W2050023063C2780221984 @default.
- W2050023063 hasConceptScore W2050023063C2780320433 @default.
- W2050023063 hasConceptScore W2050023063C2780494398 @default.
- W2050023063 hasConceptScore W2050023063C2780864610 @default.
- W2050023063 hasConceptScore W2050023063C3018162438 @default.
- W2050023063 hasConceptScore W2050023063C71924100 @default.
- W2050023063 hasConceptScore W2050023063C98274493 @default.
- W2050023063 hasIssue "6" @default.
- W2050023063 hasLocation W20500230631 @default.
- W2050023063 hasLocation W20500230632 @default.
- W2050023063 hasOpenAccess W2050023063 @default.
- W2050023063 hasPrimaryLocation W20500230631 @default.
- W2050023063 hasRelatedWork W1642075481 @default.
- W2050023063 hasRelatedWork W1973625586 @default.
- W2050023063 hasRelatedWork W1976411805 @default.
- W2050023063 hasRelatedWork W2045659791 @default.
- W2050023063 hasRelatedWork W2050023063 @default.
- W2050023063 hasRelatedWork W2072816846 @default.
- W2050023063 hasRelatedWork W2144557577 @default.
- W2050023063 hasRelatedWork W2313776227 @default.
- W2050023063 hasRelatedWork W3093992020 @default.
- W2050023063 hasRelatedWork W3177910697 @default.
- W2050023063 hasVolume "65" @default.
- W2050023063 isParatext "false" @default.
- W2050023063 isRetracted "false" @default.
- W2050023063 magId "2050023063" @default.
- W2050023063 workType "article" @default.